Department of Biomedicine
University Hospital, Klinikum 1 in Hörsaal 4
Philipp Schmassmann, Brain Tumor Immunotherapy and Biology
The Siglec-sialic acid axis is a target for innate immunotherapy of glioblastoma
Export event as iCal
Back